COMPANY PROFILE // THE 014 REPORT
Adagio Medical Holdings, Inc.
ADGM (Nasdaq) · Formerly: Aja Holdco, Inc.
Assembled from 2 government sources in 2.3 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-08-14 and 3 more times (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
Adagio Medical Holdings, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in DE, based in Laguna Hills, CA; listed as ADGM (Nasdaq).[source] It reported revenue of $0 for the fiscal year ended 2025-12-31.[source] It has filed 69 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Seraphix flags 1 item from these records: 8-K Item 3.01 filed.[source]
- red0
- amber1
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- George Dan · Interim CFO (Officer) · latest Form 3 2025-04-28 · filing · LinkedIn search
- Kaster Deborah · Chief Financial Officer (Officer) · latest Form 4 2026-03-09 · filing · LinkedIn search
- Usen Todd · Chief Executive Officer (Director,Officer) · latest Form 4 2026-03-09 · filing · LinkedIn search
- PERCEPTIVE ADVISORS LLC · Director,10% owner · latest Form 4 2025-10-22 · filing · LinkedIn search
- Salmon Sean · Director · latest Form 4 2025-12-11 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Eric Blanchard Eric Blanchard Cooley LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-03-30
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002006986 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 26051 MERIT CIRCLE, LAGUNA HILLS, CA, 92653 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-16 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-11-10 filing PRE 14A · SEC EDGAR
- 2026-11-05 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-10-26 filing 8-K items 5.07 · SEC EDGAR
- 2026-10-13 filing Proxy statement · SEC EDGAR
- 2026-10-01 filing 8-K items 3.02 · SEC EDGAR
- 2026-10-01 filing PRE 14A · SEC EDGAR
- 2026-09-23 filing 8-K items 2.05,8.01,9.01 · SEC EDGAR
- 2026-08-14 filing 8-K items 3.01 · SEC EDGAR
- 2026-08-13 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-08-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-13 filing 10-K/A · SEC EDGAR
- 2026-06-16 filing 8-K items 5.07 · SEC EDGAR
- 2026-06-12 filing 8-K items 3.01 · SEC EDGAR
- 2026-05-21 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-05-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-30 filing ARS · SEC EDGAR
- 2026-04-30 filing Proxy statement · SEC EDGAR
- 2026-04-27 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-04-20 filing 8-K items 5.08 · SEC EDGAR
- 2026-04-08 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-04-03 filing EFFECT · SEC EDGAR
- 2026-04-03 filing EFFECT · SEC EDGAR
- 2026-04-02 filing S-8 POS · SEC EDGAR
- 2026-04-02 filing POS AM · SEC EDGAR
- 2026-04-02 filing POS AM · SEC EDGAR
- 2026-04-01 filing POS AM · SEC EDGAR
157 earlier entries
- 2026-04-01 filing POS AM
- 2026-03-30 filing S-8
- 2026-03-27 filing 424B3
- 2026-03-27 filing 424B3
- 2026-03-27 filing Annual report (10-K)
- 2026-03-27 filing 8-K items 2.02,9.01
- 2025-12-16 filing 424B3
- 2025-12-16 filing 424B3
- 2025-12-16 filing 8-K items 5.07
- 2025-12-15 insider First Form 3/4/5 on record for Usen Todd (Chief Executive Officer)
- 2025-12-12 filing EFFECT
- 2025-12-12 filing 424B3
- 2025-12-12 filing 424B3
- 2025-12-12 filing 424B3
- 2025-12-11 filing DEFA14A
- 2025-12-11 officer change 8-K items 5.02
- 2025-12-11 insider First Form 3/4/5 on record for Salmon Sean (Director)
- 2025-12-10 filing CORRESP
- 2025-11-24 filing S-3
- 2025-11-12 filing 424B3
- 2025-11-12 filing 424B3
- 2025-11-12 filing Quarterly report (10-Q)
- 2025-11-12 filing 8-K items 2.02,9.01
- 2025-11-04 filing ARS
- 2025-11-04 filing Proxy statement
- 2025-10-29 filing D
- 2025-10-24 filing 424B3
- 2025-10-24 filing 424B3
- 2025-10-24 filing 8-K items 5.08
- 2025-10-22 insider First Form 3/4/5 on record for PERCEPTIVE ADVISORS LLC (Director,10% owner)
- 2025-10-20 filing 424B3
- 2025-10-20 filing 424B3
- 2025-10-20 filing 8-K items 8.01,9.01
- 2025-10-15 filing 424B3
- 2025-10-15 filing 424B3
- 2025-10-15 filing 8-K items 1.01,3.02,8.01,9.01
- 2025-10-10 filing 424B3
- 2025-10-10 filing 424B3
- 2025-10-10 filing 8-K items 8.01,9.01
- 2025-10-01 filing 424B3
- 2025-10-01 filing 424B3
- 2025-10-01 filing 8-K items 8.01,9.01
- 2025-09-30 insider First Form 3/4/5 on record for Kaster Deborah (Chief Financial Officer)
- 2025-09-08 filing 424B3
- 2025-09-08 filing 424B3
- 2025-09-08 officer change 8-K items 5.02,7.01,9.01
- 2025-08-14 filing 424B3
- 2025-08-14 filing 424B3
- 2025-08-14 filing Quarterly report (10-Q)
- 2025-08-13 filing 8-K items 2.02,7.01,9.01
- 2025-05-15 filing 424B3
- 2025-05-15 filing 424B3
- 2025-05-15 filing Quarterly report (10-Q)
- 2025-05-15 filing 8-K items 2.02,9.01
- 2025-05-01 filing 424B3
- 2025-05-01 filing 424B3
- 2025-04-30 filing 10-K/A
- 2025-04-28 insider First Form 3/4/5 on record for George Dan (Interim CFO)
- 2025-04-23 filing 424B3
- 2025-04-23 filing 424B3
- 2025-04-23 officer change 8-K items 5.02,9.01
- 2025-04-02 filing 8-K items 2.02,7.01,9.01
- 2025-03-27 filing S-8
- 2025-03-27 filing 424B3
- 2025-03-27 filing 424B3
- 2025-03-27 filing Annual report (10-K)
- 2025-03-17 filing 424B3
- 2025-03-17 filing 424B3
- 2025-03-17 officer change 8-K items 5.02,7.01,9.01
- 2025-03-04 filing 424B3
- 2025-03-04 filing 424B3
- 2025-03-04 officer change 8-K items 5.02
- 2025-02-28 filing 424B3
- 2025-02-28 filing 424B3
- 2025-02-28 filing 8-K items 7.01,9.01
- 2025-02-07 filing EFFECT
- 2025-02-07 filing EFFECT
- 2025-02-07 filing 424B3
- 2025-02-07 filing 424B3
- 2025-02-05 filing 424B3
- 2025-02-05 filing 424B3
- 2025-02-05 filing 8-K items 1.02
- 2025-02-05 filing CORRESP
- 2025-02-05 filing CORRESP
- 2025-02-04 filing S-1/A
- 2025-02-04 filing S-1/A
- 2025-01-22 filing UPLOAD
- 2025-01-22 filing UPLOAD
- 2025-01-14 filing Registration (S-1)
- 2025-01-14 filing Registration (S-1)
- 2025-01-06 filing 424B3
- 2025-01-06 filing 424B3
- 2025-01-06 filing 8-K items 1.01,3.01,9.01
- 2024-12-23 filing 424B3
- 2024-12-23 filing 424B3
- 2024-12-23 officer change 8-K items 3.01,5.02
- 2024-12-16 filing 424B3
- 2024-12-16 filing 424B3
- 2024-12-16 officer change 8-K items 1.01,5.02,7.01,9.01
- 2024-11-26 filing 424B3
- 2024-11-26 filing 424B3
- 2024-11-25 filing EFFECT
- 2024-11-25 filing EFFECT
- 2024-11-25 filing POS AM
- 2024-11-22 filing POS AM
- 2024-11-14 filing 424B3
- 2024-11-14 filing 424B3
- 2024-11-14 filing Quarterly report (10-Q)
- 2024-11-14 filing 8-K items 2.02,9.01
- 2024-11-08 filing POS AM
- 2024-11-08 filing POS AM
- 2024-11-04 filing 8-K/A items 9.01
- 2024-11-01 filing 8-K items 4.02
- 2024-10-08 filing S-8
- 2024-09-19 filing EFFECT
- 2024-09-19 filing EFFECT
- 2024-09-19 filing 424B3
- 2024-09-19 filing 424B3
- 2024-09-17 filing UPLOAD
- 2024-09-17 filing UPLOAD
- 2024-09-17 filing CORRESP
- 2024-09-17 filing CORRESP
- 2024-09-13 filing Registration (S-1)
- 2024-09-13 filing Registration (S-1)
- 2024-08-26 filing Quarterly report (10-Q)
- 2024-08-19 filing 8-K items 7.01,9.01
- 2024-08-14 filing 8-K/A items 2.01,9.01
- 2024-08-06 officer change 8-K items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,7.01,9.01
- 2024-08-01 filing CERT
- 2024-08-01 filing 8-A12B
- 2024-08-01 name change Name changed from Aja Holdco, Inc.
- 2024-07-26 filing 425
- 2024-07-23 filing 425
- 2024-07-12 filing EFFECT
- 2024-07-12 filing 424B3
- 2024-07-11 filing CORRESP
- 2024-07-11 filing CORRESP
- 2024-07-11 filing S-4/A
- 2024-07-11 filing UPLOAD
- 2024-07-02 filing 425
- 2024-06-25 filing CORRESP
- 2024-06-25 filing S-4/A
- 2024-06-25 filing 425
- 2024-06-11 filing 425
- 2024-06-03 filing 425
- 2024-05-30 filing UPLOAD
- 2024-05-16 filing 425
- 2024-05-13 filing CORRESP
- 2024-05-13 filing S-4/A
- 2024-05-03 filing UPLOAD
- 2024-05-02 filing 425
- 2024-05-02 filing 425
- 2024-04-19 filing S-4
- 2024-04-18 filing CORRESP
- 2024-03-25 filing 425
- 2024-03-12 filing UPLOAD
- 2024-02-14 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) 10-Q filed
- 2026-11-16 (within 7 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-11-10 (within 30 days) PRE 14A filed
- 2026-11-05 (within 30 days) 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-26 (within 30 days) 8-K filed: Item 5.07 shareholder vote
- 2026-10-13 (older) DEF 14A filed
- 2026-10-01 (older) 8-K filed: Item 3.02 unregistered equity sale
- 2026-10-01 (older) PRE 14A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:ADGM The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2006986 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | ADGM / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 00534B308 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002006986 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $0 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 10:22 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$25,084,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 10:22 UTC | Report an error |
| Total assets (at 2025-12-31) | $43,253,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 10:22 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $12,402,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 10:22 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $17,105,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 10:22 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Business address | 26051 MERIT CIRCLE, SUITE 102, LAGUNA HILLS, CA, 92653 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$19,014,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 10:22 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $374,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 10:22 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $21,040,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-20 10:22 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $718,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D total offering amount (D filed 2025-10-29) | $49,846,793 | 2025-10-29 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D total amount sold (D filed 2025-10-29) | $18,999,999 | 2025-10-29 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D industry group | Other Health Care | 2025-10-29 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-10-29 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
| Form D date of first sale | 2025-10-17 | 2025-10-29 | D | as filed | 2026-11-20 10:22 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001104659-26-127672
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001104659-26-127672 | 2026-11-20 10:22 UTC | Report an error |
| Net income (loss) | $17,840,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001104659-26-127672 | 2026-11-20 10:22 UTC | Report an error |
| Interest expense | $843,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-16 | 0001104659-26-127672 | 2026-11-20 10:22 UTC | Report an error |
| Cash and cash equivalents | $3,095,000 | at 2026-09-30 | 10-Q | 2026-11-16 | 0001104659-26-127672 | 2026-11-20 10:22 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing 10-Q filed
- 2026-11-16 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-11-10 Filing PRE 14A filed
- 2026-11-05 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-26 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-10-13 Filing DEF 14A filed
- 2026-10-01 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-10-01 Filing PRE 14A filed
- 2026-09-23 Filing 8-K filed: Item 2.05 exit or disposal costs; Item 8.01 other event; Item 9.01 exhibits
- 2026-08-14 Filing 8-K filed: Item 3.01 delisting notice
- 2026-08-13 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-11 Filing 10-Q filed
- 2026-08-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-13 Filing 10-K/A filed (FORM 10-K/A)
- 2026-06-16 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-06-12 Filing 8-K filed: Item 3.01 delisting notice
- 2026-05-21 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-05-12 Filing 10-Q filed
- 2026-05-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-30 Filing ARS filed
- 2026-04-30 Filing DEF 14A filed
- 2026-04-27 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-04-20 Filing 8-K filed: Item 5.08
- 2026-04-08 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-04-03 Filing EFFECT filed
8-K item text, as filed (excerpts)
- 2026-11-16 8-K Item 2.02, Results of Operations and Financial Condition
On November 16, 2026, Adagio Medical Holdings, Inc. issued a press release announcing financial results for the quarter ended September 30, 2026, and providing a business update. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference. The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set… the 8-K · retrieved 2026-11-20 10:22 UTC - 2026-11-05 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year. On November 4, 2026, Adagio Medical Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect a one-for-thirty (1-for-30) reverse stock split (the “Reverse Stock Split”) of its outstanding common stock. The Amendment will be effective at 5:00 p.m. Eastern Time on November 6, 2026. A series of alternate amendments to effect a reverse stock split was approved by the Company’s stockholders at the Company’s Special Meeting of Stockholders held on October 23, 2026 and the specific one-for thirty (1-for-30) Reverse Stock Split was… the 8-K · retrieved 2026-11-20 10:22 UTC - 2026-10-26 8-K Item 5.07, Submission of Matters to a Vote of Security Holders
On October 23, 2026, Adagio Medical Holdings, Inc.’s (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting”). The stockholders considered one proposal which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on October 13, 2026 (the “Proxy Statement”). Of the 27,439,328 shares outstanding as of the record date, 14,582,518 shares, or 53.14%, were present or represented by proxy at the Special Meeting. The final results for the matter submitted to the stockholders at the Special Meeting is as follows: Proposal No 1: Approval of a series of alternate amendments to the Company’s Amended and Restated… the 8-K · retrieved 2026-11-20 10:22 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2006986.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002006986. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.